The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Dolberg, O. T.
* Articles by Grunhaus, L.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Dolberg, O. T.
* Articles by Grunhaus, L.
Am J Psychiatry 155:1119-1121, August 1998
©Copyright 1998 American Psychiatric Association


Brief Report

Melatonin for the Treatment of Sleep Disturbances in Major Depressive Disorder

Ornah T. Dolberg, M.D., Schmuel Hirschmann, M.D., and Leon Grunhaus, M.D.

OBJECTIVE: The authors' goal was to examine the hypnotic effects of slow-release melatonin during the initial 4 weeks of treatment with fluoxetine in 19 patients with major depressive disorder. METHOD: Twenty-four outpatients with major depressive disorder were included in the study; 19 completed the study. Ten patients were treated with fluoxetine plus slow-release melatonin and nine were given fluoxetine plus placebo in a double-blind protocol for 4 weeks. Response was assessed by using rating scales for depression and sleep. RESULTS: The 10 patients given slow-release melatonin reported significantly better scores on the Pittsburgh Sleep Quality Index than the nine patients given placebo. No significant differences in the rate of improvement in depressive symptoms were noted between the two groups. No particular side effects were noted from the combination of fluoxetine and slow-release melatonin. CONCLUSIONS: Slow-release melatonin was effective in improving the sleep of patients with major depressive disorder. Slow-release melatonin had no effect on the rate of improvement in symptoms of major depressive disorder. The authors conclude that the role of slow-release melatonin for sleep disturbances in major depressive disorder should be investigated further. (Am J Psychiatry 1998; 155:1119–1121)




This article has been cited by other articles:


Home page
J PsychopharmacolHome page
M. Fava
Pharmacological approaches to the treatment of residual symptoms
J Psychopharmacol, May 1, 2006; 20(3_suppl): 29 - 34.
[Abstract] [PDF]


Home page
Psychiatr. Bull.Home page
T. Brugha, H. Rampes, and R. Jenkins
Surely you take complementary and alternative medicines?
Psychiatr. Bull., February 1, 2004; 28(2): 36 - 39.
[Abstract] [Full Text] [PDF]


Home page
Complementary Health Practice ReviewHome page
J. Zuess
An Integrative Approach to Depression: Part 2--Assessment and Treatment
Complementary Health Practice Review, April 1, 2003; 8(2): 99 - 115.
[Abstract] [PDF]


Home page
CLIN PEDIATRHome page
A. Ivanenko, V. M. Crabtree, R. Tauman, and D. Gozal
Melatonin in Children and Adolescents with Insomnia: A Retrospective Study
Clinical Pediatrics, January 1, 2003; 42(1): 51 - 58.
[Abstract] [PDF]


Home page
J. Nutr.Home page
M. Zaouali-Ajina, A. Gharib, G. Durand, N. Gazzah, B. Claustrat, C. Gharib, and N. Sarda
Dietary Docosahexaenoic Acid-Enriched Phospholipids Normalize Urinary Melatonin Excretion in Adult (n-3) Polyunsaturated Fatty Acid-Deficient Rats
J. Nutr., November 1, 1999; 129(11): 2074 - 2080.
[Abstract] [Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 1998 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org